Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 2 days ago • ZTS
Zoetis Gears Up to Report Q1 Earnings: Is a Beat in the Cards?
Zacks Investment Research • 3 days ago • ZTS
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks Investment Research • 5 days ago • ZTS
Zoetis (ZTS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks Investment Research • 5 days ago • ZTS
Here's Why Zoetis (ZTS) is a Strong Value Stock
The Motley Fool • 8 days ago • ZTS
This Animal Health Stock Is Trading at Its Lowest P/E Ratio Ever
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.